Equity
€36,611 from €207,114 in 2020
Equity fell by 82% in 5 years.
SIMENAC
Lifetime
8 annual accounts with figures on one time axispeak €336,530 (2024)
€218,459▼ 35.1%
lowest -€4,128 (2021)
€157,364▼ 36.6%
peak €207,114 (2020)
€36,611▼ 67.7%
€120,901▼ 38.5%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
15-07-202616 days before the deadline
2025micro format
Gross margin from €336,530 to €218,459Result from €248,289 to €157,364Dividend €234,000Equity from €113,246 to €36,611Debts from €196,723 to €120,901Investments €15,550
Key points
from the 2025 annual accountsTurnover
≈ €410,000 estimated
The micro format states no turnover.
Debts
€120,901 77% of the balance sheet
Suppliers 28%Taxes and wages 28%Other 43%
Investments
€15,550 7.9 × depreciation
Green is investment, beige is depreciation. Machinery stands 95.6% higher than in 2024.
Filings
8 annual accounts 5 late
The 2023 accounts came latest: 91 days after the end of the period.
Position in the sector
€157,364
Higher net result than 81% of companies in human health. Sector median €59,563 · 21,309 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,715 companies had the same profile as SIMENAC has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,715 companies, not a prediction for SIMENAC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0688724051
Appointment: (director)
“Ten dien einde is de vennootschap bevoegd om alle handelingen die daartoe noodzakelijk of nuttig zijn. Dit…” (deed in Dutch) · General meeting of 19-07-2023 · Gazette deed
Registered office moved from Kontich to Boechout
New registered office: Lispersteenweg 119, 2530 Boechout · Previous registered office: Edegemsesteenweg 76, 2550 Kontich · General meeting of 06-01-2021 · Gazette deed
Incorporation
Founding capital of €18,600, 186 shares, €12,400 paid up · Founder: · Appointment: (manager) · published on 24-01-2018 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SIMENAC Boechout | €157,512 | €218,459 | 23.2% | - |
| Dr.Sophie Van Malderen Cardioloog Bornem | €149,971 | €211,943 | 12.7% | - |
| DOKTER KATRIEN LAUWERS Antwerp | €165,834 | €243,441 | 52.3% | - |
| DR ATHANASIADIS Braine-l'Alleud | €149,078 | €217,408 | 16.8% | - |
| Moro Cassiano Saint-Hubert | €163,543 | €212,170 | 92.3% | - |
| Marie VANDERSTICHELEN Anesthésiste Mettet | €162,521 | €210,816 | 0.1% | - |
| DR. BARBARA WILLANDT Oostkamp | €144,527 | €240,871 | 70.0% | - |
These companies have the same main activity as SIMENAC: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €145,000 and €166,000, founded between 2016 and 2019.
Official details
Source: KBO- Status
- Active since 22-01-2018Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.272.380.6932530 Boechout, since 22-01-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 26-11-2024
Annual accounts 2025
- €157,512▼ 49.2%
- Filing
- Filed on 15-07-2026, 16 days before the end of the filing period
Insights on SIMENAC
SIMENAC files the micro format. That format states no turnover. The gross margin rose from €81,096 in 2018 to €218,459 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SIMENAC
- What is the company number of SIMENAC?
- The company number of SIMENAC is 0688.724.051. The VAT number is the same number with BE in front: BE 0688.724.051.
- Where is SIMENAC based?
- The registered office is at Lispersteenweg 119, 2530 Boechout.Company details
- What does SIMENAC do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of SIMENAC?
- SIMENAC is a private limited company (BV).
- When was SIMENAC founded?
- SIMENAC was founded on 22-01-2018.
- Is SIMENAC still active?
- Yes, SIMENAC is an active enterprise in the KBO register.
- What is the turnover of SIMENAC?
- The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €218,459 and 40 comparable companies (NACE 86220). It probably lies between €340,000 and €540,000.Financials
- Is SIMENAC profitable?
- In financial year 2025, SIMENAC made a profit of €157,364.
- Where can I find the annual accounts of SIMENAC?
- SIMENAC filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SIMENAC due?
- SIMENAC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.